Top 5 Low Price Stocks To Buy For 2019

Growth versus value investing is one of the major debates in the investment world.  Growth stocks seem to have outperformed their value counterparts over the past few years. But the winning streak of growth investing took a hit this year with value stocks regaining lost glory.

It is currently speculated that value investing will likely continue its winning run in the upcoming years. Hence, adding potential stocks to one’s portfolio might prove to be an ideal option in the current scenario.

Value vs. Growth Investing: Long-Drawn Debate

Value investors seek to invest in stocks that are believed to be trading at a discounted value. Investors look for favorable value ratios including low price-to-earnings (P/E) and price-to-book value (P/B) ratios to identify potential value stocks. While a significant number of these stocks are also expected to come with solid dividend payments, these stocks are also expected to moderate growth prospects.

Top 5 Low Price Stocks To Buy For 2019: B. Riley Financial, Inc.(RILY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Broadridge Financial Solutions (NYSE: BR) and B. Riley Financial (NASDAQ:RILY) are both business services companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, institutional ownership and dividends.

  • [By Motley Fool Transcribers]

    B. Riley Financial Inc  (NASDAQ:RILY)Q4 2018 Earnings Conference CallMarch 05, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By WWW.GURUFOCUS.COM]

    For the details of Standard General L.P.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Standard+General+L.P.

    These are the top 5 holdings of Standard General L.P.National CineMedia Inc (NCMI) – 12,576,000 shares, 60.53% of the total portfolio. New PositionTime Inc (TIME) – 3,181,424 shares, 29.62% of the total portfolio. Turning Point Brands Inc (TPB) – 305,319 shares, 3.58% of the total portfolio. Shares added by 189.90%CafePress Inc (PRSS) – 2,500,000 shares, 3.12% of the total portfolio. New PositionB. Riley Financial Inc (RILY) – 167,736 shares, 1.97% of the total portfoli

  • [By Logan Wallace]

    B. Riley Financial (NASDAQ:RILY) will post its quarterly earnings results after the market closes on Tuesday, March 5th.

    RILY opened at $17.17 on Monday. B. Riley Financial has a fifty-two week low of $13.60 and a fifty-two week high of $23.70. The company has a debt-to-equity ratio of 5.54, a current ratio of 4.34 and a quick ratio of 4.34. The firm has a market cap of $446.11 million, a PE ratio of 10.77 and a beta of 1.27.

Top 5 Low Price Stocks To Buy For 2019: Guggenheim S&P Global Water ETF (CGW)

Advisors’ Opinion:

  • [By Logan Wallace]

    Jane Street Group LLC bought a new stake in shares of Invesco S&P Global Water Index ETF (NYSEARCA:CGW) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 209,583 shares of the company’s stock, valued at approximately $7,019,000.

Top 5 Low Price Stocks To Buy For 2019: TESARO, Inc.(TSRO)

Advisors’ Opinion:

  • [By Cory Renauer]

    All of these biotech stocks have been battered for different reasons, and bouncing back will be a lot easier for some than for others. 

    Company (Symbol) One-Month Loss  Market Capitalization
    Idera Pharmaceuticals (NASDAQ:IDRA) (35%) $199.7 million
    Spark Therapeutics (NASDAQ:ONCE) (38%) $2.16 billion
    Tesaro (NASDAQ:TSRO) (40%) $1.49 billion

    Here’s what needs to happen if these stocks are going to mount a comeback.

  • [By Ethan Ryder]

    Here are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

    Get TESARO alerts:

    TESARO Partners With the Pan-Mass Challenge for 2018 Ride Benefiting Dana-Farber Cancer Institute (finance.yahoo.com) TESARO Inc Expected to Post FY2021 Earnings of $3.00 Per Share (TSRO) (americanbankingnews.com) TESARO (TSRO) Draws $200 Million From Second Tranche of Non-Dilutive Term Loan Financing (streetinsider.com) TESARO Draws $200 Million From Second Tranche of Non-Dilutive Term Loan Financing (finance.yahoo.com) Tesaro to sell Varubi rights for U.S. and Canada to TerSera for $40M (seekingalpha.com)

    A number of equities analysts recently commented on TSRO shares. Bank of America reduced their price objective on shares of TESARO from $94.00 to $88.00 and set a “buy” rating for the company in a research note on Friday, May 4th. Citigroup reduced their price objective on shares of TESARO from $102.00 to $100.00 and set a “buy” rating for the company in a research note on Friday, May 4th. Argus reduced their price objective on shares of TESARO from $154.00 to $110.00 and set a “buy” rating for the company in a research note on Wednesday, May 2nd. Lake Street Capital set a $120.00 price objective on shares of TESARO and gave the stock a “buy” rating in a research note on Sunday, April 22nd. Finally, HC Wainwright reissued a “buy” rating and issued a $108.00 price objective on shares of TESARO in a research note on Tuesday, March 27th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and sixteen have given a buy rating to the company’s stock. TESARO currently has a consensus rating of “Buy” and a consensus price target of $111.24.

  • [By Paul Ausick]

    Tesaro Inc. (NASDAQ: TSRO) traded down more than 10% Wednesday and posted a new 52-week low of $44.51 after closing Tuesday at $49.63. The stock’s 52-week high is $168.92. Volume totaled around 3 million, approaching three times the daily average of around 1.1 million. European banks were hit hard by events in Italy, but Santander had no specific news.

  • [By Ethan Ryder]

    TESARO (NASDAQ:TSRO)‘s stock had its “hold” rating reissued by stock analysts at Jefferies Financial Group in a report issued on Friday. They presently have a $38.00 price target on the biopharmaceutical company’s stock. Jefferies Financial Group’s price objective indicates a potential upside of 7.71% from the company’s current price.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Top 5 Low Price Stocks To Buy For 2019: Imperial Oil Limited(IMO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Citadel Advisors LLC purchased a new stake in shares of Imperial Oil Ltd (NYSEAMERICAN:IMO) (TSE:IMO) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 44,728 shares of the energy company’s stock, valued at approximately $1,487,000.

  • [By Logan Wallace]

    Imperial Oil Ltd (NYSEAMERICAN:IMO) (TSE:IMO) saw a significant increase in short interest during the month of June. As of June 15th, there was short interest totalling 11,491,321 shares, an increase of 1.1% from the May 31st total of 11,363,187 shares. Based on an average trading volume of 400,912 shares, the days-to-cover ratio is presently 28.7 days.

  • [By Shane Hupp]

    Swiss National Bank cut its position in shares of Imperial Oil (NYSEAMERICAN:IMO) (TSE:IMO) by 6.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,066,300 shares of the energy company’s stock after selling 76,100 shares during the period. Swiss National Bank owned approximately 0.13% of Imperial Oil worth $28,203,000 at the end of the most recent quarter.

Top 5 Low Price Stocks To Buy For 2019: Transcananda Pipelines Ltd.(TRP)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    TransCanada (NYSE:TRP) recently closed the books on a record year by delivering strong fourth-quarter results. The Canadian energy infrastructure giant placed 4 billion Canadian dollars ($3 billion) of expansion projects into service, which helped drive full-year earnings and cash flow up by 16%. Meanwhile, with another CA$9 billion ($6.8 billion) of capital projects nearing completion and several billion more in the pipeline, the company expects to continue growing at a healthy rate for the next several years.

  • [By Reuben Gregg Brewer]

    The shares of giant diversified Canadian midstream company TransCanada Corporation (NYSE:TRP) rose an impressive 19% in January, according to data provided by S&P Global Market Intelligence. That was a huge turn from last year, when the S&P 500 Index’s late-year swoon helped to push TransCanada’s stock down a painful 26%. For reference, the S&P was down around 6% in 2018 and rose roughly 8% in January.

  • [By Matthew DiLallo]

    Most investors have probably heard of energy giants Royal Dutch Shell (NYSE:RDS-A) (NYSE:RDS-B), Dominion Energy (NYSE:D), and TransCanada (NYSE:TRP). Fewer, however, are likely familiar with their publicly traded master limited partnerships (MLPs): Shell Midstream Partners (NYSE:SHLX), Dominion Energy Midstream Partners (NYSE:DM), and TC Pipelines (NYSE:TCP). That might be a good thing, as the market has beaten up the latter trio this year, sending their valuations south.

  • [By Logan Wallace]

    Enterprise Products Partners (NYSE: TRP) and TC PIPELINES LP Common Stock (NYSE:TRP) are both large-cap oils/energy companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.

Leave a Reply

Your email address will not be published. Required fields are marked *